Health
Oxford begins first-of-its-kind trial study to reinfect recovered Coronavirus patients – Republic TV
Oxford to begin its first study of reinfecting recovered patients with the virus. Researchers are looking for 64 healthy, previously Covid-infected volunteers
As Oxford begins its first-of-its-kind trial study that may help to shed light on how to develop a more effective vaccine against the Coronavirus infection, people who have fought off with the COVID-19 virus will be deliberately reinfected. The UK University on Monday said that the researchers are looking for 64 healthy, previously COVID-19 infected volunteers from 18 to 30 years of age to be studied under controlled, quarantine conditions for at least 17 days. Participants will be infected with…
-
Noosa News17 hours agoMotorbike rider dies after car collision at Kidaman Creek, west of Sunshine Coast
-
General18 hours agoDemocratic senators want an investigation into potential market manipulation from Trump’s inner circle
-
Business23 hours agoDown 20% this year, here are 3 reasons why I’m still loading up on Amazon stock
-
General23 hours agoStocks, dollar sink as trade war roils markets